27.06.2023 • NewsAmgenHorizon TherapeuticsFTC

Six States Join FTC Lawsuit to Block Amgen-Horizon

Six US states – New York, California, Illinois, Wisconsin, Minnesota and Washington – have joined the Federal Trade Commission's lawsuit to block Amgen's proposed nearly $28 billion acquisition of Horizon Therapeutics.

Citing antitrust considerations, the group of six filed an amended complaint backing the FTC’s opposition to the transaction on grounds it would give Amgen "monopoly positions" for medicines used to treat thyroid eye disease and chronic refractory gout.

In a statement, California Attorney General Rob Bonta said the acquisition would be “dangerous for the future of medicine, dangerous for innovation and research, and most importantly, dangerous for sick people in need of often lifesaving drugs.”

Washington Attorney General Bob Ferguson said the state had joined the lawsuit because "monopolies harm consumers" and the merger could allow Amgen to "dominate" prescription drug markets.

© Shutterstock/Nito
© Shutterstock/Nito

Amgen has had its sights trained on Horizon for some time, finally unveiling its plans in December 2022. Since being announced, the acquisition drive has been on a rocky road, with the FTC twice asking the company for more information.

In response to a temporary restraining order obtained by the FTC, Amgen last month agreed not to close the deal before Oct. 31 or the second business day after the court rules on the trade watchdog’s request to block it. A US district judge has set Sept. 11 as the date to hear the request.

Initially, the companies said they hoped to conclude the transaction in the first half of 2023.

Author: Dede Williams, Freelance Journalist

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.